Mitsu Chem Plast Targets ₹1,000 Cr Revenue by FY28 on Strong Q4

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Mitsu Chem Plast Targets ₹1,000 Cr Revenue by FY28 on Strong Q4
Overview

Mitsu Chem Plast reported a Q4 FY26 net profit of ₹7.71 crore on ₹86.79 crore in revenue. The company is aiming for ₹1,000 crore in annual revenue by FY28, driven by capacity expansion, new products in packaging and healthcare furniture, and growing global exports.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Mitsu Chem Plast Sets Ambitious ₹1,000 Crore Revenue Target for FY28

Mitsu Chem Plast reported a net profit of ₹7.71 crore on revenue of ₹86.79 crore for the fourth quarter of FY26. The company has set an ambitious goal to achieve ₹1,000 crore in annual revenue by fiscal year 2028, signalling a significant growth push.

Financial Performance and Future Goals

Mitsu Chem Plast shared its investor presentation for Q4 FY26, reporting total income of ₹86.79 crore. The company achieved an EBITDA of ₹14.23 crore and a net profit of ₹7.71 crore for the quarter. For the full fiscal year 2025, the company reported revenues of ₹333 crore. Looking ahead, the company aims to achieve ₹1,000 crore in annual revenue by FY28.

Driving Growth: Strategy and Focus

This ambitious target signals a major growth push for Mitsu Chem Plast, highlighting a strategic focus on expanding market share and revenue. The company aims to achieve this goal through innovation, capacity expansion, and operational efficiency. Key priorities include strengthening its Furnastra hospital furniture brand and broadening its packaging product offerings.

Capacity Expansion Fuels Growth Plans

Mitsu Chem Plast is actively enhancing its production capacity to support its growth strategy. In November 2025, the company announced an expansion of approximately 655 MT per year, funded by ₹85 lakh from internal accruals. Earlier, in January 2026, it was reported that a new facility in Boisar was planned, expected to add around 900 MTPA capacity with an investment of ₹101 lakh. These investments are designed to meet rising demand and help achieve the ₹1,000 crore revenue target by FY28.

Investor Outlook: What to Expect

Investors can expect a sharpened focus on executing the company's growth strategy. This includes increased investment in capacity expansion and product development. The company will also place greater emphasis on strengthening the Furnastra brand and expanding its packaging product portfolio. Furthermore, Mitsu Chem Plast aims to enhance its global export presence, which currently reaches 17 countries.

Key Risks to Monitor

The company's future performance may be influenced by factors such as the performance of Indian and international economies, competitive pressures, successful execution of its growth strategies, and general market risks.

Industry Peers

Mitsu Chem Plast operates in both industrial packaging and hospital furniture segments. Key competitors in packaging include Uflex Ltd., Jindal Poly Films Ltd., and Mold-Tek Packaging Ltd. In the hospital furniture market, peers include Godrej Interio, Midmark India Pvt. Ltd., and Narang Medical Limited.

Future Milestones to Watch

Investors will be watching progress towards the ₹1,000 crore revenue target by FY28. Key performance indicators include the growth of the Furnastra brand, expansion of packaging products, capacity utilization rates, and efficiency improvements. The company's success in increasing its export markets, acquiring new customers, and integrating new facilities like the one in Boisar will also be closely monitored.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.